恆生(00011.HK)附屬訂有限責任合夥協議 斥10.25億美元作私募股本投資
恆生銀行(00011.HK)宣佈,於7月8日(今日),全資附屬恆生保險與匯豐控股(00005.HK)兩間全資附屬HGGP及HMGL訂立《有限責任合夥協議》。
根據該協議,恆生保險以投資者身份,而HGGP則以普通合夥人身份,設立了H8 LP,用以進行私募股本投資。
恆生保險已經同意向H8 LP合共認繳出資10.25億美元,在2021年間進行投資。H8 LP獲授權按照HMGL的決定,於2021年進行最多8.35億美元信貸投資性質的投資、最多1.55 億美元私募股本性質的投資;以及最多3,500萬美元基礎建設股本性質的投資,但前提是必須遵照若幹投資指引的規定。此等金額是按照恆生保險的投資策略而釐訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.